Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

Completed · Phase 4

Conditions studied: Dry Eye

In brief

To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.

Key facts

Study ID

NCT00622037

Run by

Bp Consulting, Inc

People needed

70

Starts

2008-02-01

Expected to finish

2008-05-01

Last updated by the study team

2010-02-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patient reported dry eye symptoms (episodic, annoying, activity limiting), SES OD.
• Physician assessment of mild-moderate dry eye
• Patient willing to instill drops QID and complete entire length of protocol.
• TBUT < 10 seconds
• BCVA of 20/30 or better

You may not qualify if…

• Current topical cyclosporine use (Restasis)
• Current Systane use
• Refractive surgery within the last 6 months
• Oral or topical corticosteroid use
• Severe dry eye patients by physician assessment
• current active Blepharitis
• Oral Doxycyclines use
• Oral Antihistamine use

Where it is running

• Florida Microsurgical Eye Institute — Boynton Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.